Literature DB >> 25501897

Stem cell autograft and allograft in autoimmune diseases.

Angelo De Cata1, Angela Matarangolo2, Michele Inglese2, Rosa Rubino3, Gianluigi Mazzoccoli4.   

Abstract

Autoimmune diseases are characterized by an insufficiency of immune tolerance and, although treated with a number of useful drugs, may need more unconventional therapeutic strategies for their more severe presentations. Among such unconventional therapeutic approaches, stem cell autograft and allograft have been used, with the aim of stimulating disease remission by modifying the pathogenic mechanisms that induce anomalous responses against self-antigens. Autologous transplantation is performed with the purpose of retuning autoimmune cells, whereas allogeneic transplantation is performed with the purpose of replacing anomalous immune effectors and mediators. In this article, we comprehensively review up-to-date information on the autoimmune diseases for which the transplantation of stem cells is indicated.

Entities:  

Keywords:  Allogeneic; Autoimmune disease; Autologous; Stem cell; Transplant

Mesh:

Year:  2014        PMID: 25501897     DOI: 10.1007/s10238-014-0330-5

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  74 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behcet disease.

Authors:  Gabriele Rossi; Antonia Moretta; Franco Locatelli
Journal:  Blood       Date:  2004-01-15       Impact factor: 22.113

3.  Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration.

Authors:  A M Marmont; M T van Lint; F Gualandi; A Bacigalupo
Journal:  Lupus       Date:  1997       Impact factor: 2.911

4.  Outcome of rheumatoid arthritis and psoriasis following autologous stem cell transplantation for hematologic malignancy.

Authors:  H M Cooley; J A Snowden; A P Grigg; I P Wicks
Journal:  Arthritis Rheum       Date:  1997-09

5.  Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease.

Authors:  Yu Oyama; Robert M Craig; Ann E Traynor; Kathleen Quigley; Laisvyde Statkute; Amy Halverson; Mary Brush; Larissa Verda; Barbara Kowalska; Nela Krosnjar; Morris Kletzel; Peter F Whitington; Richard K Burt
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

6.  Long-term prognosis and causes of death in systemic lupus erythematosus.

Authors:  Andrea Doria; Luca Iaccarino; Anna Ghirardello; Sandra Zampieri; Silvia Arienti; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Antonio Piccoli; Silvano Todesco
Journal:  Am J Med       Date:  2006-08       Impact factor: 4.965

7.  Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study.

Authors:  A Fassas; A Anagnostopoulos; A Kazis; K Kapinas; I Sakellari; V Kimiskidis; A Tsompanakou
Journal:  Bone Marrow Transplant       Date:  1997-10       Impact factor: 5.483

8.  Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.

Authors:  Rachele Ciccocioppo; Maria Ester Bernardo; Adele Sgarella; Rita Maccario; Maria Antonietta Avanzini; Cristina Ubezio; Antonella Minelli; Costanza Alvisi; Alessandro Vanoli; Fabrizio Calliada; Paolo Dionigi; Cesare Perotti; Franco Locatelli; Gino Roberto Corazza
Journal:  Gut       Date:  2011-01-21       Impact factor: 23.059

9.  Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Karina A Keogh; Mark E Wylam; John H Stone; Ulrich Specks
Journal:  Arthritis Rheum       Date:  2005-01

10.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.